Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-26 @ 2:23 AM
Study NCT ID:
NCT04591002
Status:
RECRUITING
Last Update Posted:
2025-06-26
First Post:
2020-09-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-08
First Submit QC Date:
None
Study First Post Date:
2020-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-20
Last Update Post Date:
2025-06-26
Last Update Post Date Type:
ACTUAL